Sonoma Pharmaceuticals, Inc. (SNOA) — key financial figures for fiscal year 2026 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2026)

$19.5M

Net Income/Loss (FY2026)

-$3.2M

Total Assets (FY2026)

$14.0M

Total Equity (FY2026)

$3.1M

Cash Flows from Operating Activities (FY2026)

-$3.9M

Source: Sonoma Pharmaceuticals, Inc. 10-K filing (FY2026). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.